Dynamics of cytokine and antibody responses in community versus hospital SARS-CoV-2 infections.
Saved in:
| Title: | Dynamics of cytokine and antibody responses in community versus hospital SARS-CoV-2 infections. |
|---|---|
| Authors: | Singh T; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, United States.; Duke Global Health Institute, Durham, NC, United States., Macintyre AN; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.; Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC, United States., Burke TW; Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC, United States.; Center for Infectious Disease Diagnostics and Innovation, Duke University, Durham, NC, United States., Anderson J; Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC, United States.; Center for Infectious Disease Diagnostics and Innovation, Duke University, Durham, NC, United States., Petzold E; Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC, United States.; Center for Infectious Disease Diagnostics and Innovation, Duke University, Durham, NC, United States., Stover EL; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States., French MJ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States., Oguin TH 3rd; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States., Demarco T; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States., McClain MT; Duke Global Health Institute, Durham, NC, United States.; Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC, United States.; Center for Infectious Disease Diagnostics and Innovation, Duke University, Durham, NC, United States.; Division of General Internal Medicine, Department of Medicine, Duke School of Medicine, Durham, NC, United States., Ko ER; Center for Infectious Disease Diagnostics and Innovation, Duke University, Durham, NC, United States.; Division of General Internal Medicine, Department of Medicine, Duke School of Medicine, Durham, NC, United States., Park LP; Duke Global Health Institute, Durham, NC, United States.; Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC, United States., Denny T; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States., Sempowski GD; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.; RTI International, Research Triangle Park, NC, United States., Woods CW; Duke Global Health Institute, Durham, NC, United States.; Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC, United States.; Center for Infectious Disease Diagnostics and Innovation, Duke University, Durham, NC, United States.; Division of General Internal Medicine, Department of Medicine, Duke School of Medicine, Durham, NC, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2024 Nov 22; Vol. 15, pp. 1468871. Date of Electronic Publication: 2024 Nov 22 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2024.1468871 |
